ArticlePloS one2026
Implementation and product- and process evaluation of a co-created gender-informed and culturally-sensitive toolkit to improve symptom recognition and care seeking for ischemic heart disease: RE-AIM framework.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTailored health messaging can be used to improve symptom recognition of ischemic heart disease (IHD) and reduce barriers to care. Therefore, we propose that a gender-informed and culturally-sensitive toolkit for health messaging could improve health outcomes by promoting adequate care seeking in the community. Hence, we will develop, implement, and evaluate a toolkit to improve IHD-related symptom recognition and care seeking in an ethnically-diverse population.
methodsWe developed a toolkit in co-creation with patients, citizens, community leaders, and healthcare professionals. Subsequently, we pilot-implemented the toolkit through organizing information sessions in four different community-based settings. Finally, using a mixed-methods design, we evaluated the Reach, Effectiveness, Adoption, Implementation, and Maintenance of the toolkit (RE-AIM), including its effect on knowledge gain on symptom recognition and care seeking,.
resultsApproximately 240 people attended the information sessions, of whom 69% women, and the mean age was 63 (standard deviation 10.7) years old. Our results showed a small increase [varying from 53.4-74.4% pre-test to 67.6-85.4% post-test] in knowledge about IHD symptoms. A great willingness to adoption the intervention was observed among the targeted community leaders, and despite several points of improvement, including fidelity to the implementation, attendees and community leaders reflected positively on the toolkit. The main challenge regarding the maintenance of the toolkit was a lack of experience in organizing community events by potential maintenance organizations.
conclusionWhile the co-created toolkit was well-received, and findings concerning the reach, adoption, and implementation were positive, the (cost)effectiveness should be further evaluated to study the long-term impact of the intervention. Moreover, the need for integration of the intervention in current infrastructure constituted a challenge to the maintenance of the toolkit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.